David Spencer, MD, director of the Comprehensive Epilepsy Center and professor of neurology at Oregon Health and Science University, previews the American Academy of Neurology (AAN) annual meeting for 2023 and says that attendees can expect not only to learn but also to leave feeling humbled and inspired.
Attendees can expect to leave the American Academy of Neurology (AAN) 75th annual meeting humbled and inspired, while participating in high-quality programming along the way, says David Spencer, MD, director of the Comprehensive Epilepsy Center and professor of neurology at Oregon Health and Science University.
Transcript
What can attendees look forward to at the AAN 2023 Annual Meeting?
The AAN has always been one of my favorite meetings to go to. I've been going pretty regularly for the last 20 years or so. I think people correctly think about it as being the premier place to go for cutting-edge research and hearing about what's hot off the press in neurology, which is correct.
They also have amazing educational programs, so that's been one of the things that I've really enjoyed going to. I work in a specialized field, so it's an opportunity to learn about things that I don't see every day. And the quality of the programming for education is really, really high.
I think also there's still a little bit of pent-up postpandemic need to get together and see people. So, it's always fun, at an in-person meeting, to just run across somebody in the hallway you haven't seen for a couple of years, meet up with people who are working in a similar area, and identify people who are potential collaborators and researchers in the future.
I always leave and have a mix of being humbled about everything that's happening that I'm not doing and inspired by a lot of new ideas.
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
AXS25: Health Policy, Drug Costs, and AI Highlights From the Conference
May 6th 2025Asembia’s AXS25 Summit covered a variety of relevant topics in the pharmaceutical industry, from the effects of the new administration to how artificial intelligence (AI) is reshaping the patience experience.
Read More
Addressing KRAS Resistance, RAS(ON) Therapies Find Limelight at AACR
May 5th 2025KRAS-targeted therapies, including daraxonrasib and zoldonrasib, show promise in overcoming resistance in cancer treatment, as highlighted at the 2025 meeting of the American Association for Cancer Research (AACR).
Read More